Overview

Melatonin for Prevention of Kidney Injury

Status:
Not yet recruiting

Trial end date:
2026-01-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.

Phase:

Phase 3

Details

Lead Sponsor:

Rutgers, The State University of New Jersey

Treatments:

Melatonin